Yet a substantial proportion (up to 40% of PD-L1+ and 50% of PD-L1low/–) of TNBCs are classified as “cold tumors.” Therefore, PD-L1 expression does not seem to be the primary determinant of “cold tumor” status for both CRCs and TNBC. The gene discussed is CD274; the disease is neoplasm.